NEWS
PRODUCT | PEOPLE | POTENTIAL – OUR CHAT WITH VERINNOGEN
September 21, 2021
Our CEO, Dr Isaac Johnson spoke to Jazz Jones from ADLIB recruitment for the series ‘Product | People | Potential’, designed to feature and showcase the very best UK start-ups with great potential.

INVEST IN INNOVATION 2021
September 3, 2021
Watch Verinnogen pitch at the "Invest in Innovation 2021" conference where we'll be among 14 other outstanding start-ups from the Innovation Forum's ImagineIF! program competing for a place on their accelerator programme alongside £10k non-dilutive funding. Should be a cracker!

VERINNOGEN MAKES THE GLOBAL TOP 15 IN THE INNOVATION FORUM'S IMAGINEIF! COMPETITION
July 16, 2021
After hundreds of applications from around the globe and making it through to the local finals in Cambridge, we are delighted to be named in the top 15 for Innovation Forum's ImagineIF! competition. Later this year we will get the opportunity to pitch in the Global Final. Stay posted!

UPCOMING EVENTS
BIOFORWARD - ROADMAP FOR GROWTH CONFERENCE
Thursday 23rd September
BioForward is a packed one-day event that provides R&D business leaders with the knowledge, skills, connectivity and services required to achieve sustainable commercial success.
IMAGINEIF! GLOBAL FINALS - INVEST IN INNOVATION VIRTUAL CONFERENCE
9th-10th November 2021
IMAGINE IF! is a leading global competition and pre-acceleration program for science-based ventures. IMAGINE IF! provides early-stage science startups with extensive opportunities to take your venture to the next level: tailored mentorship, the potential to secure non-dilutive capital, free advice from leading professional service companies and rapid networking across the Innovation Forum’s platform.
INSITUTE OF ANIMAL TECHNOLOGY WEBINAR
November 2021 (TBD)
The IAT's purpose is to advance knowledge and promote excellence in the care and welfare of animals in research and to enhance the standards and status of those professionally engaged in the care, welfare and use of animals in science. Verinnogen will discuss how it's latest technology will benefit pre-clinical cancer research.